search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Lock Out Slush Contamination


... automatically Closed slush system ends


troublesome sterility issues and erases prolonged, ambient exposure.


NEWSWIRE


with all buildings designed to meet LEED standards.


The new location in Grayslake, IL is estimated to be the largest medical-grade distribution center in the world. Other distribution centers on track to complete in 2021 are: Hammond, LA, Mebane, NC, Montgomery, NY, Richmond Hill, GA, Southaven, MI, and St. Peters, MO. By continuing to further control the delivery to customers with Goods-to- Person technologies and expanding its private fl eet to more than 1,200 MedTrans trucks, Medline enabled: • Better overall building utilization • Pick/pack/ship nearly two to three times faster than manual method


• 24-hour turnarounds from order receipt to customer delivery


• Improved accuracy of deliveries to customers by over 20%


S SLUSHurgiSLUSH Programmable Auto-Freezers with Protective Container SystemTM TM


• Increased resilience with proprietary technology solutions and cybersecurity Over the past three years, Medline has also expanded manufacturing capabili- ties across North America. Most recently, Medline expanded its manufacturing facility in Lithia Springs, GA as part of its North American Manufacturing Expan- sion (NAME) initiative to produce face masks with a mix of foreign and domestic materials, its fi rst time manufacturing them in the U.S. In 2021, the company plans to install a second line and ulti- mately anticipates producing more than 36 million face masks per month. Medline is also focusing on investing in


renewable energy to offset its carbon foot- print in communities across the country.


Infection risks related to glucose monitoring, insulin administration


Several warning alerts have been issued by the Centers for Disease Control and Prevention (CDC) regarding unsafe practices by healthcare staff conduct- ing or assisting individuals with blood glucose monitoring and insulin admin- istration. These safety issues place those staff members at risk for transmission of bloodborne viruses, such as hepatitis B and C or HIV.


°CChange S U R G I C A L


www.cchangesurgical.com


HealthTrust | GSA | MAGNET Group Visit www.ksrleads.com/?106hp-041


8


The Joint Commission has found that there are knowledge gaps among provid- ers and/or organizational leaders that have resulted in unsafe practices and subsequent escalation to an Immediate Threat to Health or Safety.


In “Focusing on Infection Control Risks: Glucose Monitoring and Insulin Admin-


June 2021 • HEALTHCARE PURCHASING NEWS • hpnonline.com


istration,” Sylvia Garcia-Houchins, RN, MBA, CIC, Director, Infection Preven- tion and Control, The Joint Commission, examines some of the more common mistakes witnessed by The Joint Com- mission when staff perform glucose monitoring using shared blood glucose devices, insulin pens and other medica- tion cartridges, which create a risk of spreading bloodborne viruses. The Joint Commission has several stan- dards that relate to this issue: •Human Resources (HR) Standard HR.01.05.03: Staff participate in ongo- ing education and training.


•Element of Performance (EP) 1: Staff participate in ongoing education and training to maintain or increase their competency and, as needed, when staff responsibilities change. Staff participa- tion is documented. •HR.01.06.01: Staff are competent to per- form their responsibilities.


•EP 5: Staff competence is initially assessed and documented as part of orientation. •Infection Prevention and Control (IC) Standard IC.02.01.01: The hospital implements its infection prevention and control plan.


•EP 2: The hospital uses standard pre- cautions, including the use of personal protective equipment, to reduce the risk of infection.


•IC.02.02.01: The hospital reduces the risk of infections associated with medi- cal equipment, devices and supplies.


•EP 1: The hospital implements infection prevention and control activities when doing the following: Cleaning and per- forming low-level disinfection of medi- cal equipment, devices and supplies. •Leadership (LD) Standard LD.04.01.07: The hospital has policies and proce- dures that guide and support patient care, treatment and services.


•EP 1: Leaders review, approve, and manage the implementation of policies and procedures that guide and support patient care, treatment, and services. •Waived Testing (WT) Standard WT.03.01.01: Staff and licensed inde- pendent practitioners performing waived tests are competent.


•EP 4: Staff and licensed independent practitioners who perform waived testing that requires the use of an instru- ment have been trained on its use and maintenance. The training on the use and maintenance of an instrument for waived testing is documented. HPN


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66